Review of Checkpoint Immunotherapy for the Management of Non-Small Cell Lung Cancer

ImmunoTargets and Therapy - New Zealand
doi 10.2147/itt.s125070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immune Checkpoint Modulation for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

The Lancet
Medicine
2019English

Immune-Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer Patients

Jurnal Respirasi
2020English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy – Authors' Reply

The Lancet
Medicine
2019English

P3.01-56 Hyperprogression and Pseudoprogression in Patients With Non-Small Cell Lung Cancer on Checkpoint Blocking Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy